Cytokinetics (CYTK) PT Raised to $36 at Piper Sandler
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $75.87 --0%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 8
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 8
Join SI Premium – FREE
Piper Sandler analyst Edward A. Tenthoff raised the price target on Cytokinetics (NASDAQ: CYTK) to $36.00 (from $33.00) while maintaining a Overweight rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
- Ypsomed Holding AG (YPSN:SW) PT Raised to CHF480 at Barclays
- MTU Aero Engines (MTX:GR) (MTUAY) PT Raised to EUR390 at Berenberg
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
